Sanders calls price of a rare disease drug 'immoral exploitation' - STAT

Sanders calls price of a rare disease drug 'immoral exploitation' - STAT

STAT Plus: Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

By ED SILVERMAN

ALEX WONG/GETTY IMAGES

Sanders accused Catalyst of “corporate greed” for charging a $375,000 list price for Firdapse, which is used to contain Lambert-Eaton myasthenic syndrome.

READ MORE